Solicitation Number: 75N95025Q00154
Date Added: March 04, 2025
(i) This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95025Q00154 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial product or commercial service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services, and is not expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-03, with effective date January 17, 2025.
(iv) The associated NAICS code is 811210 and the small business size standard is $34 million. This requirement is full and open with no set-aside restructions.
(v) This requirement is for the following services: Service and maintenance for WOLF G2 Cell Sorter with N1 Pro attachment. Please see the attached Statement of Work (SOW) for detailed requirements.
(vi) The National Institute on Aging (NIA) Laboratory of Cardiovascular Science (LCS) requires maintenance services for a WOLF G2 Cell Sorter (Serial# 001032) with a N1 Pro attachment (Serial# 00204) manufactured by NanoCellect Biomedical, Inc. The WOLF G2 Cell Sorter with a N1 Pro attachment is a critical instrument used for research of cardiac Ribonucleic acid (RNA) workflow.
(vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated period of performance is:
Base Period: March 24, 2025 – November 30, 2025
Option Year One: December 1, 2025 – November 30, 2026
Option Year Two: December 1, 2026 – November 30, 2027
Option Year Three: December 1, 2027 – November 30, 2028
(viii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses:
https://www.acquisition.gov/browse/index/far
https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html
https://www.acquisition.gov/caac-letters
(End of provision)
The following provisions apply to this acquisition and are incorporated by reference:
The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the
Set-Aside: N/A (N/A)
Place of Performance: Baltimore, Maryland, UNITED STATES
NAICS Codes:
811210
Files:
SAM.gov
Sep 16, 2026 Active